Company filings profile · CIK 0001372514
KIORA PHARMACEUTICALS INC — SEC filings & insider activity.
Real, source-linked SEC EDGAR activity for KIORA PHARMACEUTICALS INC (KPRX): 27 filings in the last 90 days vs 7 in the prior 90 (filing-velocity rising ↑ · 3.86×). Latest material 8-K events, insider Form-4 transactions, and periodic reports — monitored for change.
✔ Verified against the public SEC EDGAR filing record as of Jun 21, 2026. Source-linked, daily-refreshed.
Material 8-K events — KIORA PHARMACEUTICALS INC
8-K disclosures decoded by item code (the material events: agreements, results, control/management changes, impairments, restatements).
| Filed | Event | |
|---|---|---|
| Jun 18, 2026 | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 11, 2026 | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| May 8, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Apr 7, 2026 | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 2, 2026 | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 25, 2026 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 7, 2025 | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
Watch KIORA PHARMACEUTICALS INC automatically
Add this company to a watchlist and get a webhook/email the moment it files a material 8-K, an insider Form 4, or changes its risk-factor language.
Insider transactions (Form 4 / 3 / 5)
Recent filings
| Filed | Form | Detail | |
|---|---|---|---|
| Jun 18, 2026 | 8-K | Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Jun 12, 2026 | 4 | FORM 4 | ↗ |
| Jun 12, 2026 | 4 | FORM 4 | ↗ |
| Jun 12, 2026 | 4 | FORM 4 | ↗ |
| Jun 12, 2026 | 4 | FORM 4 | ↗ |
| Jun 12, 2026 | 4 | FORM 4 | ↗ |
| Jun 12, 2026 | 4 | FORM 4 | ↗ |
| Jun 11, 2026 | 8-K | Departure/Election of Directors or Officers; Item 5.07; Financial Statements and Exhibits | ↗ |
| May 28, 2026 | 424B3 | 424B3 | ↗ |
| May 22, 2026 | EFFECT | Item ; Item ; Item | ↗ |
| May 18, 2026 | S-3 | S-3 | ↗ |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 15, 2026 | SCHEDULE 13G | ↗ | |
| May 15, 2026 | SCHEDULE 13G/A | ↗ | |
| May 8, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| May 8, 2026 | 10-Q | 10-Q | ↗ |
| May 1, 2026 | ARS | ARS - 10-K | ↗ |
| Apr 30, 2026 | DEF 14A | DEF 14A | ↗ |
| Apr 21, 2026 | D | Item 06b | ↗ |
| Apr 7, 2026 | 8-K | Entry into a Material Agreement; Unregistered Sale of Securities; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Apr 2, 2026 | 4 | FORM 4 | ↗ |
| Apr 2, 2026 | 4 | FORM 4 | ↗ |
| Apr 2, 2026 | 4 | FORM 4 | ↗ |
| Apr 2, 2026 | 8-K | Departure/Election of Directors or Officers; Regulation FD Disclosure; Financial Statements and Exhibits | ↗ |
| Mar 25, 2026 | S-8 | S-8 | ↗ |
| Mar 25, 2026 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Mar 25, 2026 | 10-K | 10-K | ↗ |
| Mar 10, 2026 | 4 | FORM 4 | ↗ |
| Mar 10, 2026 | 4 | FORM 4 | ↗ |
| Mar 10, 2026 | 4 | FORM 4 | ↗ |
| Mar 6, 2026 | 4 | FORM 4 | ↗ |
| Mar 6, 2026 | 4 | FORM 4 | ↗ |
| Feb 11, 2026 | SCHEDULE 13G/A | ↗ | |
| Jan 29, 2026 | SCHEDULE 13G/A | ↗ | |
| Nov 14, 2025 | SCHEDULE 13G/A | ↗ | |
| Nov 7, 2025 | 8-K | Results of Operations (earnings); Financial Statements and Exhibits | ↗ |
| Nov 7, 2025 | 10-Q | 10-Q | ↗ |
| Sep 19, 2025 | EFFECT | Item ; Item ; Item | ↗ |
| Sep 17, 2025 | CORRESP | ↗ | |
| Sep 16, 2025 | UPLOAD | ↗ |